Insider Trading May 5, 2026 12:52 PM

Old Republic International Director Executes Insider Stock Purchase Amid Recent Earnings Volatility

Director Risch Therace acquires 300 shares as the company navigates missed Q1 expectations and updated analyst price targets.

By Hana Yamamoto ORI
Old Republic International Director Executes Insider Stock Purchase Amid Recent Earnings Volatility
ORI

Old Republic International Corp (NASDAQ:ORI) has seen recent insider activity following a period of mixed financial results. On May 1, 2026, Risch Therace, a member of the company's board of directors, completed a purchase of common stock. This transaction occurred while the company was managing the aftermath of a first-quarter earnings report that fell below consensus estimates and amid adjustments to price targets by financial analysts.

Key Points

  • Director Risch Therace purchased 300 shares of ORI at $39.90 per share.
  • The company reported Q1 2026 EPS of $0.68, missing the $0.80 estimate.
  • Raymond James lowered its price target from $47 to $44 while keeping a Strong Buy rating.

Insider Transaction Details

On May 1, 2026, Old Republic International Corp director Risch Therace increased his stake in the company through a direct purchase of common stock. The transaction involved the acquisition of 300 shares at a price of $39.90 per share, representing a total investment of $11,970. Following this specific buy, Therace holds a total of 12,843 shares of the company's common stock directly, a figure that includes 1,918 unvested restricted stock units.

This purchase took place while the stock was trading at $38.90, which is positioned near its 52-week low of $35.60. Despite the recent price movement, analysis suggests the company remains undervalued at its current valuation levels.


Recent Financial Performance and Market Outlook

The insider buying follows a first-quarter 2026 earnings release that presented several challenges for Old Republic International. The company reported earnings per share (EPS) of $0.68, which failed to meet the forecasted $0.80. This resulted in a negative surprise of 15% relative to analyst expectations. Furthermore, revenue for the quarter was recorded at $2.2 billion, missing anticipated figures by 3.08%.

In response to these metrics and an analysis of the company's 2026 estimated price-to-book value per share, Raymond James recently updated its outlook on the stock. The firm lowered its price target for Old Republic International from $47 to $44, although it maintained a Strong Buy rating for the shares.

Key Analysis Points

  • Insider Confidence: The direct acquisition of shares by a director can be viewed as an indicator of internal perspective on current valuation.
  • Dividend Consistency: Old Republic International maintains a notable 9.8% dividend yield and has a documented history of 56 consecutive years of maintaining dividend payments.
  • Earnings Discrepancy: The recent gap between reported EPS and forecasted EPS highlights a period of performance volatility that market participants are monitoring.

Risks and Uncertainties

  • Earnings Misses: The 15% negative surprise in EPS and the revenue miss of 3.08% represent immediate financial hurdles for the company.
  • Price Target Reductions: While maintaining a positive rating, the downward revision of the price target by Raymond James reflects shifts in valuation expectations based on book value estimates.
  • Market Volatility: With the stock trading near its 52-week low, there is inherent uncertainty regarding near-term price stability.

Risks

  • Earnings and revenue underperformance relative to analyst expectations.
  • Downward adjustment of price targets by analysts based on book value estimates.
  • Stock trading near 52-week lows, indicating recent downward pressure.

More from Insider Trading

Planet 13 Holdings Executive Executes Common Stock Sale May 5, 2026 Trio Petroleum Director Executes Share Sale for Tax Obligations Amid Equity Program Adjustments May 5, 2026 Major Shareholder Elwood G. Norris Divests Wrap Technologies Stock Amid Recent Price Decline May 5, 2026 Edgewise Therapeutics CMO Executes $2.09 Million Stock Sale via Pre-Set Trading Plan May 5, 2026 AI Era Corp. President Executes Significant Common Stock Acquisition May 5, 2026